Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
KeifeRx Logo
KeifeRx Growth Score
45
CB Rank
86551
Heat Score
61
KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses.
Founded
obfuscation
PrivateSeries A Mclean, Virginia, United States1-10 www.keiferx.com
Biopharma
Biotechnology
Pharmaceutical
Overview

KeifeRx
Total Funding
obfuscation
Growth Score
45
Heat Score
61

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score45
-8 pts
in past quarter
Heat Score 61
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About KeifeRx

CB Rank
86551
KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses.
Founded
obfuscation
PrivateSeries A Mclean, Virginia, United States1-10 www.keiferx.com
Biopharma
Biotechnology
Pharmaceutical

Funding Rounds

Series A
OBF
in
obfuscation

Key People

Details

Legal Name KeifeRx, LLC
Operating Status Active
Company Type For Profit
Founders  Charbel Moussa, Fernando Pagan
About the Company
KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses. Founded in 2019 and is based in McLean, Virginia.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Nilotinib
An orally delivered kinase inhibitor targeting c-ABL, c-KIT, and FYN to clear toxic proteins in neurodegenerative diseases like Alzheimer's and Parkinson's.
KFRX03
An orally bioavailable kinase inhibitor targeting c-ABL and DDR-1 for treatment of Alzheimer's disease and Parkinson's disease dementia.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - KeifeRx Logo
Series A - KeifeRx
—
obfuscation
— Series A
obfuscation
Series A - KeifeRx Logo
Series A - KeifeRx
—
obfuscation
— Series A
obfuscation
Series A - KeifeRx Logo
Series A - KeifeRx
—
obfuscation
— Series A
obfuscation
Series A - KeifeRx Logo
Series A - KeifeRx
—
obfuscation
— Series A
obfuscation
Series A - KeifeRx Logo
Series A - KeifeRx
—
obfuscation
— Series A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - KeifeRx Logo
Series A - KeifeRx
—
obfuscation
— Series A
obfuscation
Series A - KeifeRx Logo
Series A - KeifeRx
—
obfuscation
— Series A
obfuscation
Series A - KeifeRx Logo
Series A - KeifeRx
—
obfuscation
— Series A
obfuscation
Series A - KeifeRx Logo
Series A - KeifeRx
—
obfuscation
— Series A
obfuscation
Series A - KeifeRx Logo
Series A - KeifeRx
—
obfuscation
— Series A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Board Members and Advisors 2 Contacts 2

Employee Profiles

Board Members and Advisors

News

News and Press

News•Apr 14, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 9, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 9, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

4

Interest Signals

TopicSurge Score
Corporate gifting Logo
Corporate gifting
84
Product Lining Logo
Product Lining
84
Sustainable Product Development Logo
Sustainable Product Development
84

Active Website Tech Count

3KeifeRx is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 10m and  Envoy.

Total IP

1KeifeRx has 1 registered trademark in the 'Scientific and technological services' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is KeifeRx's headquarters? KeifeRx is located in Mclean, Virginia, United States.When was the last funding round for KeifeRx? KeifeRx closed its last funding round on
obfuscation
from a Series A round.Who are KeifeRx's competitors? Alternatives and possible competitors to KeifeRx may include CervoMed, Annovis Bio, and  Alzheon.How much funding has KeifeRx raised to date? KeifeRx has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(92fa32f 1)
|